X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with VENUS REMEDIES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs VENUS REMEDIES - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS VENUS REMEDIES J.B.CHEMICALS/
VENUS REMEDIES
 
P/E (TTM) x 16.6 -3.7 - View Chart
P/BV x 2.3 0.1 1,612.1% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 J.B.CHEMICALS   VENUS REMEDIES
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
VENUS REMEDIES
Mar-18
J.B.CHEMICALS/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs318126 252.7%   
Low Rs20061 326.5%   
Sales per share (Unadj.) Rs148.0301.8 49.0%  
Earnings per share (Unadj.) Rs19.1-24.9 -76.7%  
Cash flow per share (Unadj.) Rs23.92.5 941.1%  
Dividends per share (Unadj.) Rs0.500-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs128.9293.3 44.0%  
Shares outstanding (eoy) m84.8212.34 687.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.70.3 564.5%   
Avg P/E ratio x13.6-3.8 -360.7%  
P/CF ratio (eoy) x10.836.7 29.4%  
Price / Book Value ratio x2.00.3 629.5%  
Dividend payout %2.60-   
Avg Mkt Cap Rs m21,9511,154 1,902.5%   
No. of employees `0002.70.9 295.6%   
Total wages/salary Rs m1,841393 468.4%   
Avg. sales/employee Rs Th4,590.94,026.1 114.0%   
Avg. wages/employee Rs Th673.4425.0 158.5%   
Avg. net profit/employee Rs Th592.1-331.8 -178.4%   
INCOME DATA
Net Sales Rs m12,5513,724 337.0%  
Other income Rs m54223 2,407.1%   
Total revenues Rs m13,0933,747 349.5%   
Gross profit Rs m2,055395 520.4%  
Depreciation Rs m412338 121.9%   
Interest Rs m96354 27.0%   
Profit before tax Rs m2,088-275 -758.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m46932 1,484.5%   
Profit after tax Rs m1,619-307 -527.4%  
Gross profit margin %16.410.6 154.4%  
Effective tax rate %22.5-11.5 -195.7%   
Net profit margin %12.9-8.2 -156.5%  
BALANCE SHEET DATA
Current assets Rs m7,7782,638 294.9%   
Current liabilities Rs m4,3582,305 189.1%   
Net working cap to sales %27.28.9 304.7%  
Current ratio x1.81.1 155.9%  
Inventory Days Days55135 40.4%  
Debtors Days Days8046 172.7%  
Net fixed assets Rs m5,7134,871 117.3%   
Share capital Rs m170123 137.4%   
"Free" reserves Rs m10,5473,496 301.7%   
Net worth Rs m10,9373,619 302.2%   
Long term debt Rs m01,374 0.0%   
Total assets Rs m15,5747,509 207.4%  
Interest coverage x22.80.2 10,234.5%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.80.5 162.5%   
Return on assets %11.00.6 1,743.8%  
Return on equity %14.8-8.5 -174.5%  
Return on capital %20.01.6 1,261.9%  
Exports to sales %48.70-   
Imports to sales %7.113.9 51.0%   
Exports (fob) Rs m6,115NA-   
Imports (cif) Rs m889517 172.0%   
Fx inflow Rs m6,1690-   
Fx outflow Rs m1,285517 248.8%   
Net fx Rs m4,884-517 -945.6%   
CASH FLOW
From Operations Rs m1,397514 271.5%  
From Investments Rs m-320-123 260.2%  
From Financial Activity Rs m-1,196-387 308.9%  
Net Cashflow Rs m-1024 -2,435.7%  

Share Holding

Indian Promoters % 55.4 32.9 168.6%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 0.2 1,883.3%  
FIIs % 3.9 0.6 672.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 66.4 55.7%  
Shareholders   30,437 20,121 151.3%  
Pledged promoter(s) holding % 0.0 36.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   AUROBINDO PHARMA  ORCHID PHARMA LTD  SANOFI INDIA  FDC LTD.  MERCK LTD  

Compare J.B.CHEMICALS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Recover; Sensex Ends 77 Points Higher(Closing)

Indian share markets witnessed buying interest during closing hours and ended on a positive note. Gains were seen in the metal sector.

Related Views on News

VENUS REMEDIES Announces Quarterly Results (2QFY19); Net Profit Down 16.3% (Quarterly Result Update)

Nov 23, 2018 | Updated on Nov 23, 2018

For the quarter ended September 2018, VENUS REMEDIES has posted a net profit of Rs 8 m (down 16.3% YoY). Sales on the other hand came in at Rs 809 m (down 10.6% YoY). Read on for a complete analysis of VENUS REMEDIES's quarterly results.

VENUS REMEDIES Announces Quarterly Results (1QFY19); Net Profit Down 756.1% (Quarterly Result Update)

Aug 20, 2018 | Updated on Aug 20, 2018

For the quarter ended June 2018, VENUS REMEDIES has posted a net profit of Rs 56 m (down 756.1% YoY). Sales on the other hand came in at Rs 655 m (down 16.2% YoY). Read on for a complete analysis of VENUS REMEDIES's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

It's Almost the Perfect Time to Buy This Safe Stock(The 5 Minute Wrapup)

Dec 6, 2018

My latest StockSelect recommendation ticks all the boxes of a great safe stock.

Patel's Exit, Election Results, and 4 'Must Have' Small Caps in These Exceptional Times(Profit Hunter)

Dec 11, 2018

RBI Governor's resignation is a statement of dissent with the way government is handling the economy's affairs and could lead to some serious market correction. Here's how to make the most of it.

Players in an Oligopoly Should Have Financials Like This(Chart Of The Day)

Dec 7, 2018

This stock has corrected 30% from peak and looks attractive at these valuations.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

DSP Mutual Fund's Sale of DHFL Bonds: Here's What You Need to Know(Outside View)

Dec 5, 2018

PersonalFN explains the probable reason as to why the capital market regulator has initiated DSP Mutual Fund's bond sale that caused DHFL stock to crash.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Dec 18, 2018 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 5-YR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS